NCT04840797 HeartStart HS1 Defibrillator* Event Registry
| NCT ID | NCT04840797 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Philips Clinical & Medical Affairs Global |
| Condition | Sudden Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2021-02-25 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,400 participants in total. It began in 2021-02-25 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) \& HeartStart Home (Model M5068A) Defibrillator device data.
Eligibility Criteria
Inclusion Criteria: * Have been suspected of a circulatory arrest for any cause. * Have had HeartStart HS1 Defibrillator with electrodes: Adult SMART Pads Cartridge \[REF: M5071A\], Infant/Child SMART Pads Cartridge (REF:M5072A) applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether a defibrillation shock was delivered Exclusion Criteria: * Subjects will be excluded if any of the following are present: * AED or pad use other than the HeartStart HS1 Defibrillator with above referenced Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1 AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator was used after the HeartStart HS1 AED. * AED used for training purposes.
Contact & Investigator
Gerrit Noordergraaf, MD PhD
PRINCIPAL INVESTIGATOR
Philips Healthcare
Frequently Asked Questions
Who can join the NCT04840797 clinical trial?
This trial is open to participants of all sexes, studying Sudden Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04840797 currently recruiting?
Yes, NCT04840797 is actively recruiting participants. Contact the research team at chase.wennick@philips.com for enrollment information.
Where is the NCT04840797 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT04840797 clinical trial?
NCT04840797 is sponsored by Philips Clinical & Medical Affairs Global. The principal investigator is Gerrit Noordergraaf, MD PhD at Philips Healthcare. The trial plans to enroll 1,400 participants.